This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • desferrioxamine mesylate is used in the treatment of acute iron poisoning (commonest in children and generally accidental). Desferrioxamine chelates iron and intensive therapy with desferrioxamine increases survival of those with acute iron poisoning
  • desferrioxamine may also be used in the treatment of other conditions where severe tissue iron overload may occur e.g. aplastic and other refractory anaemias - in these cases iron overload mainly occurs secondary to repeated blood transfusions. Iron overload is especially a problem in refractory anaemias associated with hyperplastic bone marrow (e.g. thalassaemia major - in this condition inappropriate iron therapy and excessive iron absorption from the gut may add to iron overload)
  • desferroixamine may also be used in haemochromatosis where venesection is contraindicated
  • iron excretion mediated via administration of desferrioxamine is enhanced via administration of vitamin C

The summary of product characteristics should be consulted before prescribing this drug.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page